 BURLINGTON, Mass., Jan. 07, 2021 GLOBE NEWSWIRE -- Flexion Therapeutics, Inc. Nasdaq:FLXN announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the ICR Westwicke Investment Conference. The virtual fireside chat is scheduled to begin at 10:45 a.m. ET on Thursday, January 14, 2021. 